An early Phase II clinical trial with followup of tomoxetine (LY139603) in the treatment of newly admitted depressed patients

Psychopharmacol Bull. 1985;21(1):73-6.
No abstract available

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use*
  • Atomoxetine Hydrochloride
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / psychology
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Propylamines / therapeutic use*

Substances

  • Antidepressive Agents
  • Propylamines
  • Atomoxetine Hydrochloride